Genetic changes associated with telomerase activity in breast cancer

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 516-520

  Loveday, Ruth L ^a   Greenman, John ^a   Drew, Philip J ^a   Monson, John R T ^a   Kerin, Michael J ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; BREAST TUMOR; CHROMOSOME 8; CHROMOSOME ABERRATION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; ONCOGENE MYC; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENES, MYC; GENES, P53; HUMANS; TELOMERASE;

EID: 0033595612     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991022)84:5<516::AID-IJC12>3.0.CO;2-Y     Document Type: Article

References (29)

1. ASM, A., KIYOZUKA, Y., YOSHIDA, R., FUJII, T., HIOKI, K. and TSUBURA, A., Telomere length, telomerase activity and telomerase RNA expression in human oesophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Anticancer Res., 18, 1465-1472(1998).
2. BEDNAREK, A.K., SAHIN, A., BRENNER, A.J., JOHNSTON, D.A. and ALDAZ, C.M., Analysis of telomerase activity levels in breast cancer: positive detection at the m situ breast carcinoma stage. Clin. Cancer Res., 1, 11-16 (1997).
3. BERNS, E.M., KLIJN, J.G., SMID, M., VAN STAVEREN, I.L, LOOK, M.P., VAN PUTTEN, W.L. and FOEKENS, J.A., TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer, 16, 170-179 (1996).
4. BURGER, A.M., DOUBLE, J.A. and NEWELL, D.R., Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Enrop. J. Cancer, 33, 638-644(1997).
5. COURJAL, F. and THEILLET, C, Comparative genomic hybridisation analysis of breast tumours with predetermined profiles of DNA amplification. Cancer Res., 57, 4368-4377 (1997).
6. HARLEY, C.B., Telomere loss: mitotic clock or genetic time bomb? Mutation R., 256, 271-282(1991).
7. HlYAMA, E., GOLLAHON, L., KATAOKA, T., KUROI, K., YOKOYAMA, T., GAZDAR, A.F., HIYAMA, K., PIATYSZEK, M.A. and SHAY, J.W., Telomerase activity in human breast tumours. J. Nat. Cancer Inst., 88, 116-122(1996).
8. HOLLSTEIN, M., SlDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
9. Hoos, A., HEPP, H.H., KAUL, S., AHLERT, T., BASTERT, G. and WALLWIENER, D., Telomerase activity correlates with tumour aggressiveness and reflects therapy effect in breast cancer. Int. J. Cancer, 79, 8-12 (1998).
10. ISOLA, J.J., KALLIONIEMI, O.P., CHU, L.W., FUQUA, S.A.W., HILSENBECK, S.G., OSBORNE, C.K. and WALDMAN, P.M., Genetic aberrations detected by comparative genomic hybridisation predict outcome in node-negative breast cancer. Amer. J. Pathol., 147, 905-911 (1995).
11. JAMES, L.A., MITCHELL, E.L., MENASCE, L. and VARLEY, J.M., Comparative genomic hybridisation of ductal carcinomas in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene, 14, 1059-1065 (1997).
12. KALLIONIEMI, A., KALLIONIEMI, O.P., PIPER, J., TANNER, M., STOKKE, T, CHEN, L., SMITH, H.S., PINKEL, D., GRAY, J.W. and WALDMAN, P.M., Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. not. Acad. Sei. (Wash.), 91, 2156-2160(1994).
13. KALLIONIEMI, A., KALLIONIEMI, O.P., SUDÀR, D., RUTOVITZ, D., GRAY, J.W., WALDMAN, F. and PINKEL, D., Comparative genomic hybridisation for molecular cytoaenetic analysis of solid tumours. Science, 258, 818-821 (1992).
14. KUUKASJARVI, T., TANNER, M., PENNANEN, S., KARHU, R., KALLIONIEMI, O.P. and ISOLA, J., Genetic changes in intraductal breast cancer detected by comparative genomic hybridisation., J. Pathol., 150, 1465-1471 (1997).
15. LANDBERG, G., NIELSEN, N.H., NILSSON, P., EMDIN, S.O., CAJANDER, J. and Roos, G., Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res., 57, 549-554 (1997).
16. MEHLE, C., LINDBLOM, A., DUNGBERG, B., STENLING, R. and Roos, G., Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Inl. J. Oncol.. 13, 289-295 (1998).
17. NAWAZ, S., HASHIZUMI, T.L., M ARKHAM, N.E., SHROYER, A.L. and SHROYER, K.R., Telomerase expression in human breast cancer with and without lymph node métastases. Amer. J. clin. Pathol, 107, 542-547(1997)..
18. NEWBOLD, R.F., Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found. Symp., 211, pp.177-189; discussion pp. 189-197 (1997).
19. NISHIZAKI, T., CHEW, K., CHU, L., ISOLA, J., KALLIONIEMI, A., WEIDNER, N. and WALDMAN, P.M., Genetic alterations in lobular breast cancer by comparative genomic hybridisation. Int. J. Cancer, 74, 513-517(1997).
20. OSHIMURA, M. and BARRETT, J.C., Multiple pathways to cellular senescence: role of telomerase repressers. Europ. J. Cancer, 33, 710-715(1997).
21. PANDIS, N., HEIM, S., BARDI, G., IDVALL, L, MANDAHL, N. and MITELMAN, F., Whole arm t(l;16) and I(lq) as sole anomalies identify gain of Iq as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer, 5, 235-238 (1992).
22. RIED, T., JUST, K.E., HOLTGREVE-GREZ, H., MANOIR, S., SPEICHER, M.R., SCHROCK, E., LATHAM, C., BLEGAN, H., ZETTERBERG, A., CREMER, T. and AUER, G., Comparative genomic hybridisation of formalin-fixed, paraffinembedded breast tumours reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res., 55, 5415-5423(1995).
23. Roos, G., NILSSON, P., CAJANDER, S., NIELSEN, N.H., ARNERLOV, C. and LANDBERG, G., Telomerase activity in relation to p53 status and clinicopathological parameters in breast cancer. Int. J. Cancer, 79, 343-348 (1998).
24. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual, pp.9-16, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
25. SODER, A.L, HOARE, S.F., MUIR, S., GOING, J.J., PARKINSON, E.K. and NICOL KEITH, \V., Amplification, increased dosage and in situ expression of the telomerase RNAgene in human cancer. Oncogene, 14, 1013-1021 (1997).
26. VAZIRI, H. and BENCHIMOL, S., From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging. Exp. Gerontol, 31, 295-301 (1996).
27. VISSCHER, D.W., WALLIS, T., AWUSSAH, S., MOHAMED, A. and CRISSMAN, J.D., Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase genetics. Genes Chromosomes Cancer, 18, 1-7 (1997).
28. WANG, J., XIE, L.Y., ALLAN, S., BEACH, D. and HANNON, G.J., Myc activates telomerase. Genes Develop., 12, 1769-1774(1998).
29. Wu, K.J., GRANDORI, C., AMACKER, M., SIMON-VERMOT, N., POLACK, A., LINGNER, J. and DALLA-FAVERA, R., Direct activation of TERT transcription by c-myc. Nature (Genet.), 21, 220-224 (1999).